Market Research Logo

Erectile Dysfunction - Pipeline Review, H1 2015

Erectile Dysfunction - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Erectile Dysfunction - Pipeline Review, H1 2015’, provides an overview of the Erectile Dysfunction’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Erectile Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Erectile Dysfunction and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Erectile Dysfunction
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Erectile Dysfunction and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Erectile Dysfunction products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Erectile Dysfunction pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Erectile Dysfunction
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Erectile Dysfunction pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Erectile Dysfunction Overview
Therapeutics Development
Pipeline Products for Erectile Dysfunction - Overview
Pipeline Products for Erectile Dysfunction - Comparative Analysis
Erectile Dysfunction - Therapeutics under Development by Companies
Erectile Dysfunction - Therapeutics under Investigation by Universities/Institutes
Erectile Dysfunction - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Unknown Stage Products
Erectile Dysfunction - Products under Development by Companies
Erectile Dysfunction - Products under Investigation by Universities/Institutes
Erectile Dysfunction - Companies Involved in Therapeutics Development
Acorda Therapeutics, Inc.
Apricus Biosciences, Inc.
Aprogen, Inc.
Bioheart, Inc.
Biolab Sanus Farmaceutica Ltda.
Corridor Pharmaceuticals Inc.
Furiex Pharmaceuticals, Inc.
Futura Medical plc
Hanmi Pharmaceuticals, Co. Ltd.
IntelGenx Corp.
Mezzion Pharma Co. Ltd.
Mitsubishi Tanabe Pharma Corporation
NAL Pharmaceuticals Ltd.
Pacific Therapeutics Ltd.
Palatin Technologies, Inc.
Pharmicell Co., Ltd.
Sagene Pharmaceuticals, Inc.
Suda Ltd
Yungjin Pharm Ind. Co., Ltd.
Erectile Dysfunction - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
AdipoCell - Drug Profile
Product Description
Mechanism of Action
R&D Progress
alprostadil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AP-102 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
BL-214 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
cimaglermin alfa - Drug Profile
Product Description
Mechanism of Action
R&D Progress
dapoxetine hydrochloride - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HCP-1302 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HCP-1303 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Immpocellgram - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MED-2002 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Next Generation Melanocortin Receptor IV Agonist - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Peptide to Activate G Protein-Coupled Receptor Mas for Cardiovascular, Metabolic Disorders and Erectile Dysfunction - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PL-6983 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
selegiline + PDE-5 Inhibitor - Drug Profile
Product Description
Mechanism of Action
R&D Progress
sildenafil citrate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
sildenafil citrate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
sildenafil citrate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit Arginase for Vascular Dysfunction, PAH and Erectile Dysfunction - Drug Profile
Product Description
Mechanism of Action
R&D Progress
T-6932 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
tadalafil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
tadalafil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
TPN-729 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
udenafil - Drug Profile
Product Description
Mechanism of Action
R&D Progress
YBH-1603 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Erectile Dysfunction - Recent Pipeline Updates
Erectile Dysfunction - Dormant Projects
Erectile Dysfunction - Discontinued Products
Erectile Dysfunction - Product Development Milestones
Featured News & Press Releases
Feb 24, 2014: IntelGenx Achieves Positive Bioequivalence Results for Erectile Dysfunction VersaFilm Tadalafil Product
Aug 28, 2012: Acorda Announces GGF2 Preclinical Data On Treatment Of Erectile Dysfunction
Jul 18, 2012: Zydus Urosciences Launches Udenafil For Treatment Of Erectile Dysfunction In India
Sep 08, 2011: Sagene Completes Pre-IND Meeting With FDA For Dual-Action Erectile Dysfunction Drug
Oct 12, 2010: Dong-A Launches Zydena For Daily Treatment Of Erectile Dysfunction In Korea
Sep 02, 2010: IntelGenx Achieves Positive Bioequivalence Results For Erectile Dysfunction Film Product
Nov 19, 2009: Once-A-Day Dosing Clinical Study Of Udenafil For Erectile Dysfunction Completed By Dong-A Pharmaceutical Co., Ltd.
Nov 11, 2009: ZYDENA Poised To Enter Global Market With Phase III Clinical Trial Starting For US FDA Approval
Sep 11, 2009: New Drug Udenafil By Dong-A PharmTech Co. Ltd For Erectile Dysfunction in US Trials
Aug 28, 2009: Dong-A Receives Approval For Zydena For Treatment Of Erectile Dysfunction
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Erectile Dysfunction, H1 2015
Number of Products under Development for Erectile Dysfunction - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Number of Products under Investigation by Universities/Institutes, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Development, H1 2015
Comparative Analysis by Unknown Stage Development, H1 2015
Products under Development by Companies, H1 2015
Products under Development by Companies, H1 2015 (Contd..1)
Products under Investigation by Universities/Institutes, H1 2015
Erectile Dysfunction - Pipeline by Acorda Therapeutics, Inc., H1 2015
Erectile Dysfunction - Pipeline by Apricus Biosciences, Inc., H1 2015
Erectile Dysfunction - Pipeline by Aprogen, Inc., H1 2015
Erectile Dysfunction - Pipeline by Bioheart, Inc., H1 2015
Erectile Dysfunction - Pipeline by Biolab Sanus Farmaceutica Ltda., H1 2015
Erectile Dysfunction - Pipeline by Corridor Pharmaceuticals Inc., H1 2015
Erectile Dysfunction - Pipeline by Furiex Pharmaceuticals, Inc., H1 2015
Erectile Dysfunction - Pipeline by Futura Medical plc, H1 2015
Erectile Dysfunction - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H1 2015
Erectile Dysfunction - Pipeline by IntelGenx Corp., H1 2015
Erectile Dysfunction - Pipeline by Mezzion Pharma Co. Ltd., H1 2015
Erectile Dysfunction - Pipeline by Mitsubishi Tanabe Pharma Corporation, H1 2015
Erectile Dysfunction - Pipeline by NAL Pharmaceuticals Ltd., H1 2015
Erectile Dysfunction - Pipeline by Pacific Therapeutics Ltd., H1 2015
Erectile Dysfunction - Pipeline by Palatin Technologies, Inc., H1 2015
Erectile Dysfunction - Pipeline by Pharmicell Co., Ltd., H1 2015
Erectile Dysfunction - Pipeline by Sagene Pharmaceuticals, Inc., H1 2015
Erectile Dysfunction - Pipeline by Suda Ltd, H1 2015
Erectile Dysfunction - Pipeline by Yungjin Pharm Ind. Co., Ltd., H1 2015
Assessment by Monotherapy Products, H1 2015
Assessment by Combination Products, H1 2015
Number of Products by Stage and Target, H1 2015
Number of Products by Stage and Mechanism of Action, H1 2015
Number of Products by Stage and Route of Administration, H1 2015
Number of Products by Stage and Molecule Type, H1 2015
Erectile Dysfunction Therapeutics - Recent Pipeline Updates, H1 2015
Erectile Dysfunction - Dormant Projects, H1 2015
Erectile Dysfunction - Dormant Projects (Contd..1), H1 2015
Erectile Dysfunction - Dormant Projects (Contd..2), H1 2015
Erectile Dysfunction - Discontinued Products, H1 2015
List of Figures
Number of Products under Development for Erectile Dysfunction, H1 2015
Number of Products under Development for Erectile Dysfunction - Comparative Analysis, H1 2015
Number of Products under Development by Companies, H1 2015
Comparative Analysis by Late Stage Development, H1 2015
Comparative Analysis by Clinical Stage Development, H1 2015
Comparative Analysis by Early Stage Products, H1 2015
Assessment by Monotherapy Products, H1 2015
Number of Products by Top 10 Targets, H1 2015
Number of Products by Stage and Top 10 Targets, H1 2015
Number of Products by Top 10 Mechanism of Actions, H1 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015
Number of Products by Top 10 Routes of Administration, H1 2015
Number of Products by Stage and Top 10 Routes of Administration, H1 2015
Number of Products by Top 10 Molecule Types, H1 2015
Number of Products by Stage and Top 10 Molecule Types, H1 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report